Morphinane derivatives containing a carboxamide group as opioid receptor ligands

Details for Australian Patent Application No. 2011232628 (hide)

Owner Rensselaer Polytechnic Institute

Inventors Wentland, Mark P.

Agent Griffith Hack

Pub. Number AU-A-2011232628

PCT Pub. Number WO2011/119605

Priority 61/316,175 22.03.10 US; 61/394,148 18.10.10 US; 61/421,915 10.12.10 US

Filing date 22 March 2011

Wipo publication date 29 September 2011

International Classifications

C07D 221/28 Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 17/00 Drugs for dermatological disorders

A61P 19/00 Drugs for skeletal disorders

A61P 25/00 Drugs for disorders of the nervous system

C07D 489/08 Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119605 Priority application(s): WO2011/119605

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011232632-Histidine rich protein-2 diagnostic test for cerebral malaria

2011232627-Crystalline forms of a macrolide, and uses therefor